| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.09 | 0.08 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.3 | 0.08 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.09 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.26 | 0.09 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |